{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:12:13Z","timestamp":1777651933501,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2023-2220"],"award-info":[{"award-number":["04-2023-2220"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HA22C0044"],"award-info":[{"award-number":["HA22C0044"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["2022-00080"],"award-info":[{"award-number":["2022-00080"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.breast.2025.104476","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:51:37Z","timestamp":1744372297000},"page":"104476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Socioeconomic disparities and osteoarthritis impact hormone therapy adherence in breast cancer"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7064-9855","authenticated-orcid":false,"given":"B.S.","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.breast.2025.104476_bib1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.bjc.6604758","article-title":"Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer","volume":"99","author":"McCowan","year":"2008","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.breast.2025.104476_bib2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/bjc.2013.116","article-title":"Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence, and mortality","volume":"108","author":"Makubate","year":"2013","journal-title":"Br J Cancer"},{"issue":"9793","key":"10.1016\/j.breast.2025.104476_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.breast.2025.104476_bib4","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor\u2013positive breast cancer: ASCO clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104476_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer","volume":"126","author":"Hershman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2025.104476_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/COC.0b013e3182436ec1","article-title":"Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women","volume":"36","author":"Weaver","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104476_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104476_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jamcollsurg.2007.07.015","article-title":"Mortality impact of less-than-standard therapy in older breast cancer patients","volume":"206","author":"Yood","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.breast.2025.104476_bib9","first-page":"9","article-title":"Association of insurance with cancer care utilization and outcomes","volume":"58","author":"Ward","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"10.1016\/j.breast.2025.104476_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/93.17.1344","article-title":"Relationship of distance from a radiotherapy facility and initial breast cancer treatment","volume":"93","author":"Nattinger","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.breast.2025.104476_bib11","first-page":"161","article-title":"Influence of comorbid conditions on adherence to adjuvant endocrine therapy in breast cancer","volume":"47","author":"Gillespie","year":"2020","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"10.1016\/j.breast.2025.104476_bib12","first-page":"981","article-title":"The role of comorbidity in breast cancer survival and treatment adherence: a population-based study","volume":"131","author":"Land","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.breast.2025.104476_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","article-title":"Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer","volume":"26","author":"Partridge","year":"2008","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.breast.2025.104476_bib14","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.24419","article-title":"Patterns and risk factors associated with aromatase inhibitor\u2013related arthralgia among breast cancer survivors","volume":"115","author":"Mao","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104476_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1200\/JCO.2001.19.2.322","article-title":"Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women","volume":"19","author":"Demissie","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104476_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/PPA.S126651","article-title":"Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review","volume":"11","author":"Moon","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.breast.2025.104476_bib17","first-page":"217","article-title":"Patterns and predictors of nonadherence to adjuvant endocrine therapy among women with breast cancer","volume":"179","author":"Wu","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.breast.2025.104476_bib18","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.breast.2025.104476_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2\u20133","key":"10.1016\/j.breast.2025.104476_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"9","key":"10.1016\/j.breast.2025.104476_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"issue":"446","key":"10.1016\/j.breast.2025.104476_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.breast.2025.104476_bib23","first-page":"197","article-title":"Factors associated with endocrine therapy adherence among hormone receptor\u2013positive breast cancer survivors: a population-based cohort study using group-based trajectory modeling","volume":"168","author":"Garneau","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"14","key":"10.1016\/j.breast.2025.104476_bib24","first-page":"1421","article-title":"Association between patient characteristics and adherence to adjuvant endocrine therapy in a diverse population-based sample","volume":"30","author":"Henry","year":"2012","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.breast.2025.104476_bib25","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2008.19.2419","article-title":"Adjuvant hormonal therapy use among insured, low-income women with breast cancer","volume":"27","author":"Kimmick","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104476_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41416-024-02680-0","article-title":"Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors","volume":"130","author":"Chang","year":"2024","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.breast.2025.104476_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/PPA.S126651","article-title":"Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review","volume":"23","author":"Moon","year":"2017","journal-title":"Patient Prefer Adherence"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762500493X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762500493X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:54:29Z","timestamp":1763607269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762500493X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":27,"alternative-id":["S096097762500493X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104476","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Socioeconomic disparities and osteoarthritis impact hormone therapy adherence in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104476"}}